CN Patent

CN1470239A — 睾酮经皮缓释制剂

Assigned to Individual · Expires 2004-01-28 · 22y expired

What this patent protects

本发明是用于对男性性腺功能低下患者进行睾酮替代治疗的经皮吸收制剂。将睾酮经皮吸收制剂涂敷在阴囊或其它部位的皮肤上，睾酮可透过皮肤缓慢持续地进入血液循环，不仅可有效提高睾酮的血液浓度，而且可保持睾酮血液浓度稳定，从而达到对男性性腺功能低下患者的雄激素替代治疗作用。

USPTO Abstract

本发明是用于对男性性腺功能低下患者进行睾酮替代治疗的经皮吸收制剂。将睾酮经皮吸收制剂涂敷在阴囊或其它部位的皮肤上，睾酮可透过皮肤缓慢持续地进入血液循环，不仅可有效提高睾酮的血液浓度，而且可保持睾酮血液浓度稳定，从而达到对男性性腺功能低下患者的雄激素替代治疗作用。

Drugs covered by this patent

Patent Metadata

Patent number
CN1470239A
Jurisdiction
CN
Classification
—
Expires
2004-01-28
Drug substance claim
No
Drug product claim
No
Assignee
Individual
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.